Ludlow China Fund Initiates Research Coverage on Skystar Bio-Pharmaceutical With a $2.50 Price Target Thursday February 8, 1:00 pm ET
NEW YORK, NY--(MARKET WIRE)--Feb 8, 2007 -- New York-based Ludlow China Fund initiates research coverage on Skystar Bio-Pharmaceutical (OTC BB:SKBI.OB - News), a leading bio-pharmaceutical company in China, with a price valuation target of $2.50 per share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.